Verona Pharma (VRNA) Revenue & Revenue Breakdown
Verona Pharma Revenue Highlights
Latest Revenue (Y)
$42.28M
Latest Revenue (Q)
$76.26M
Main Segment (Y)
Product
Verona Pharma Revenue by Period
Verona Pharma Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-12-31 | $42.28M | 100.00% |
2023-12-31 | - | -100.00% |
2022-12-31 | $458.00K | -98.86% |
2021-12-31 | $40.00M | 100.00% |
2020-12-31 | - | -100.00% |
2019-12-31 | $2.35K | -15.52% |
2018-12-31 | $2.78K | -99.85% |
2017-12-31 | $1.84M | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2012-12-31 | - | 100.00% |
2011-12-31 | - | 100.00% |
2010-12-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2008-12-31 | - | 100.00% |
2007-12-31 | - | 100.00% |
2006-12-31 | - | 100.00% |
2005-12-31 | - | - |
Verona Pharma generated $42.28M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 1798341.13% compared to the same period a year ago.
Verona Pharma Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2025-03-31 | $76.26M | 108.04% |
2024-12-31 | $36.66M | 551.76% |
2024-09-30 | $5.62M | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $940.06K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | -100.00% |
2022-12-31 | $458.00K | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | -100.00% |
2021-09-30 | $40.00M | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | -100.00% |
2019-12-31 | $2.35K | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | -100.00% |
2018-12-31 | $2.78K | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | -100.00% |
2017-12-31 | $1.84M | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2005-06-30 | - | - |
Verona Pharma generated $76.26M in revenue during Q1 2025, up 108.04% compared to the previous quarter, and up 8111.86% compared to the same period a year ago.
Verona Pharma Revenue Breakdown
Verona Pharma Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 24 |
---|---|
Product and Service, Other | $18.00K |
Product | $42.26M |
Latest
Verona Pharma's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (99.96%), and Product and Service, Other (0.04%).
Quarterly Revenue by Product
Product/Service | Jun 25 | Mar 25 |
---|---|---|
Product and Service, Other | $199.00K | $5.00M |
Product | $102.94M | $71.26M |
Latest
Verona Pharma's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Product (99.81%), and Product and Service, Other (0.19%).
Verona Pharma Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
BPMC | Blueprint Medicines | $508.82M | $149.41M |
RYTM | Rhythm Pharmaceuticals | $130.13M | $48.50M |
VRNA | Verona Pharma | $42.28M | $76.26M |
MRSN | Mersana Therapeutics | $40.50M | $3.06M |
IMRN | Immuron | $1.80M | $2.36M |
GPCR | Structure Therapeutics | - | - |
ETNB | 89bio | - | - |
AKRO | Akero Therapeutics | - | - |
VRDN | Viridian Therapeutics | - | - |
TERN | Terns Pharmaceuticals | - | - |
MIST | Milestone Pharmaceuticals | - | - |